Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.80%108.001.1%$623.63m
GILDGilead Sciences, Inc.
2.24%75.880.9%$553.53m
AMGNAmgen Inc.
0.81%176.831.1%$472.09m
REGNRegeneron Pharmaceuticals, Inc.
0.14%381.322.7%$367.77m
BIIBBiogen Inc.
0.69%328.031.2%$319.81m
ALXNAlexion Pharmaceuticals, Inc.
-2.24%111.901.9%$254.48m
NKTRNektar Therapeutics
2.30%55.216.1%$211.68m
VRTXVertex Pharmaceuticals Incorporated
-1.34%141.681.9%$185.36m
ALNYAlnylam Pharmaceuticals, Inc
-2.06%128.2010.0%$179.97m
BLUEBluebird Bio, Inc.
17.91%201.8017.2%$170.21m
ILMNIllumina, Inc.
-1.63%214.113.5%$161.51m
AAgilent Technologies, Inc.
-0.65%66.941.5%$153.46m
INCYIncyte Corporation
0.69%97.252.5%$138.55m
BMRNBioMarin Pharmaceutical Inc.
7.46%88.114.4%$100.29m
JUNOJuno Therapeutics, Inc.
-14.34%50.2413.5%$94.10m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.